2014国际临床和转化医学论坛

Haojie Huang, Ph.D

   2014-07-11
字体大小:

Haojie Huang, Ph.D

Haojie Huang, Ph.D., holds an Associate Professor position in the Departments of Biochemistry and Molecular Biology and Urology at Mayo Clinic, one of the top hospitals (No. 2) in the United States. Dr. Huang's research primarily focuses onregulation and function of biologically significant transcription regulators, such as transcription factors (androgen receptor (AR), ERG and FOXO1), transcription co-regulators (CBP and p300) and histone/chromatin modifiers (methyltransferase EZH2 and histone demethylase LSD1). Using the state-of-the-art approaches of mouse genetics, biochemistry and molecular and cell biology, Dr. Huang’s laboratory aims to elucidate the role of deregulated PTEN/FOXO1 pathway in prostate cancer survival, glucose and lipid metabolism and metastasis; the involvement of transcription co-regulators in prostate tumorigenesis; and the importance of chromatin microenvironment and epigenetic modulation in prostate tumorigenesis and castration-resistant progression. Findings from Dr. Huang’s research have been published in high-profile journals including Science, Nature Cell Biology, PNAS, EMBO J, Cancer Research and Cell Reports.

 

编辑: tong205    来源:丁香园

主办单位:

中国工程院(CAE)

中国医学科学院(CAMS)

美国国立卫生研究院临床研究中心

协办单位:

上海交通大学

复旦大学

同济大学

上海中医药大学

中国科学院上海生命科学研究院

更多详情>>

5月28日下午:高端论坛

5月28日全天:注册报到

5月29日上午:开幕式、大会报告

5月29日下午:分论坛

5月30日上午:分论坛

5月30日下午:闭幕式